Global Pharmaceuticals & Biotech Breakout Stocks

Moderna

Market Cap: US$57.9b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$29.3b

Engages in the development and commercialization of immunotherapies in Germany.

Genscript Biotech

Market Cap: HK$71.3b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Hanmi Pharm

Market Cap: ₩6.9t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Amylyx Pharmaceuticals

Market Cap: US$4.3b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Maravai LifeSciences Holdings

Market Cap: US$2.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Xencor

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.

Personalis

Market Cap: US$2.0b

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Jenkem Technology

Market Cap: CN¥7.5b

Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.

Immix Biopharma

Market Cap: US$977.2m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Hunan Hansen Pharmaceutical

Market Cap: CN¥5.6b

Engages in the production and sale of traditional Chinese preparations in China and internationally.

Nuvectis Pharma

Market Cap: US$767.6m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥4.9b

Operates as a pharmaceutical manufacturing holding investment company in China.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥3.7b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

ACRO Biomedical

Market Cap: NT$15.0b

Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.

ProQR Therapeutics

Market Cap: US$330.2m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Solara Active Pharma Sciences

Market Cap: ₹30.3b

Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.

AVITA Medical

Market Cap: US$311.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Circio Holding

Market Cap: NOK 2.2b

A biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.

Journey Medical

Market Cap: US$218.7m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Nykode Therapeutics

Market Cap: NOK 1.5b

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

Cypherpunk Technologies

Market Cap: US$153.0m

A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.

More Life

Market Cap: CA$34.3m

A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.

Marker Therapeutics

Market Cap: US$23.2m

A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.

Pharmala Biotech Holdings

Market Cap: CA$28.9m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

BioVie

Market Cap: US$14.7m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

Malaysian Genomics Resource Centre Berhad

Market Cap: RM 57.4m

Provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia.

Makers Laboratories

Market Cap: ₹1.3b

An integrated pharmaceutical company, manufactures and markets formulations in India.

TME Pharma

Market Cap: €8.4m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

International Stem Cell

Market Cap: US$4.0m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Emmaus Life Sciences

Market Cap: US$2.3m

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Orgenesis

Market Cap: US$980.0k

A biotech company, focuses on cell and gene therapies in the United States.

PAO Group

Market Cap: US$573.1k

Focuses on alternative patient care treatments.

Neutra

Market Cap: US$304.3k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Cannonau

Market Cap: US$48.4k

Engages in the provision of cannabidiol based products.